eedq has been researched along with ketanserin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biggio, G; Giorgi, O | 1 |
| Battaglia, G; Creese, I; Norman, AB | 1 |
| Battaglia, G; Creese, I; Newton, PL; Norman, AB | 1 |
| Battaglia, G; Pinto, W | 1 |
4 other study(ies) available for eedq and ketanserin
| Article | Year |
|---|---|
Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Ergolines; Ketanserin; Male; Motor Activity; Prazosin; Quinolines; Quinpirole; Raclopride; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Yohimbine | 1990 |
Differential serotonin2 receptor recovery in mature and senescent rat brain after irreversible receptor modification: effect of chronic reserpine treatment.
Topics: Adrenergic alpha-Antagonists; Aging; Animals; Brain; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Ketanserin; Kinetics; Male; Quinolines; Rats; Rats, Inbred F344; Receptors, Serotonin; Reserpine | 1987 |
In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
Topics: Animals; Cerebral Cortex; Domperidone; Dose-Response Relationship, Drug; Ketanserin; Kinetics; Male; Piperidines; Quinolines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin | 1986 |
In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Brain; Carrier Proteins; Cerebral Cortex; Dose-Response Relationship, Drug; Iodocyanopindolol; Ketanserin; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Paroxetine; Pindolol; Quinolines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins | 1993 |